achilles physical therapy, p.c.

310 east 53rd st., ste 30c
new york, new york 10022

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 24, 2013

NYS DOS ID#
4408563

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION

Name History
2013 - ACHILLES PHYSICAL THERAPY, P.C.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • The Rebuilding Years, Post-Sandy
    By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017

    Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.

    Source: NYT > Home Page
  • Nets’ Achilles heel exposed with Knicks’ relentless effort
    By Brian Lewis - Saturday Oct 28, 2017

    The Nets haven’t kept opponents off the offensive glass so far this season, but on Friday night, they took that to all kinds of new lows. With the Nets playing a heretofore winless Knicks team, this wasn’t shirts and skins. This looked more like hobbits versus giants. The Nets got humiliated on the boards and...

    Source: New York Post: Sports
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Why MLB managers succumb to their late-inning Achilles’ heel
    By Phil Mushnick - Monday Aug 14, 2017

    With all the debating teams on cable TV and radio, here’s an idea that may be worth shelving Carmelo Anthony issues for a few minutes: If Major League Baseball was supposed to be played the way it’s now played, would it have survived for over 100 years? Would it now be a popular spectator sport...

    Source: New York Post: Sports